Literature DB >> 26860611

The Emerging Roles of Leadless Devices.

Jeffrey Arkles1, Joshua Cooper2.   

Abstract

OPINION STATEMENT: The role of leadless devices to treat cardiac rhythm disorders and heart failure is emerging. Subcutaneous defibrillator (S-ICD) and leadless pacemakers were developed to ameliorate the risks associated with chronic transvenous leads. Potential benefits of leadless pacemakers and S-ICD include more favorable infection profile, less risk of venous stenosis or occlusion, and less risk of tricuspid valve insufficiency. Novel implantable leadless monitors for heart failure represent a novel diagnostic tool that can guide therapy for CHF.

Entities:  

Keywords:  Heart failure; ICD; Implantable monitor; Pacemaker

Year:  2016        PMID： 26860611     DOI： 10.1007/s11936-015-0424-8

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


  23 in total

1.  Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.

Authors:  Haitham Hreybe; Eathar Razak; Samir Saba
Journal:  Pacing Clin Electrophysiol       Date:  2007-09       Impact factor: 1.976

2.  Who should receive the subcutaneous implanted defibrillator?: Timing is not right to replace the transvenous implantable cardioverter defibrillator.

Authors:  Moshe Rav Acha; David Milan
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-12

3.  Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Authors:  Raul Weiss; Bradley P Knight; Michael R Gold; Angel R Leon; John M Herre; Margaret Hood; Mayer Rashtian; Mark Kremers; Ian Crozier; Kerry L Lee; Warren Smith; Martin C Burke
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

Review 4.  Tricuspid valve incompetence following implantation of ventricular leads.

Authors:  Giselle A Baquero; Jerry Luck; Gerald V Naccarelli; Mario D Gonzalez; Javier E Banchs
Journal:  Curr Heart Fail Rep       Date:  2015-04

5.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

Authors:  William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav
Journal:  Lancet       Date:  2011-02-19       Impact factor: 79.321

6.  Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening.

Authors:  Louise R A Olde Nordkamp; Joppe L F Warnaars; Kirsten M Kooiman; Joris R de Groot; Boudewijn R A M Rosenmöller; Arthur A M Wilde; Reinoud E Knops
Journal:  J Cardiovasc Electrophysiol       Date:  2014-01-07

7.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Authors:  Louise R A Olde Nordkamp; Lara Dabiri Abkenari; Lucas V A Boersma; Alexander H Maass; Joris R de Groot; Antonie J H H M van Oostrom; Dominic A M J Theuns; Luc J L M Jordaens; Arthur A M Wilde; Reinoud E Knops
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

8.  Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.

Authors:  Reinoud E Knops; Louise R A Olde Nordkamp; Joris R de Groot; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2013-05-21       Impact factor: 6.343

9.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

10.  Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study.

Authors:  Philippe Ritter; Gabor Z Duray; Clemens Steinwender; Kyoko Soejima; Razali Omar; Lluís Mont; Lucas V A Boersma; Reinoud E Knops; Larry Chinitz; Shu Zhang; Calambur Narasimhan; John Hummel; Michael Lloyd; Timothy Alexander Simmers; Andrew Voigt; Verla Laager; Kurt Stromberg; Matthew D Bonner; Todd J Sheldon; Dwight Reynolds
Journal:  Eur Heart J       Date:  2015-06-04       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.